Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:TR1 - US74144T1088 - Common Stock

92.76 EUR
+2.02 (+2.23%)
Last: 1/15/2026, 7:00:00 PM
Fundamental Rating

7

Overall TR1 gets a fundamental rating of 7 out of 10. We evaluated TR1 against 127 industry peers in the Capital Markets industry. While TR1 has a great health rating, its profitability is only average at the moment. TR1 may be a bit undervalued, certainly considering the very reasonable score on growth Finally TR1 also has an excellent dividend rating. With these ratings, TR1 could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year TR1 was profitable.
  • In the past year TR1 had a positive cash flow from operations.
  • TR1 had positive earnings in each of the past 5 years.
  • In the past 5 years TR1 always reported a positive cash flow from operatings.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

  • The Return On Assets of TR1 (13.79%) is better than 93.60% of its industry peers.
  • TR1 has a better Return On Equity (18.78%) than 75.20% of its industry peers.
  • TR1's Return On Invested Capital of 13.51% is amongst the best of the industry. TR1 outperforms 91.20% of its industry peers.
  • TR1 had an Average Return On Invested Capital over the past 3 years of 15.27%. This is significantly above the industry average of 8.63%.
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROIC 13.51%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 28.18%, TR1 is in the better half of the industry, outperforming 74.40% of the companies in the same industry.
  • TR1's Profit Margin has declined in the last couple of years.
  • The Operating Margin of TR1 (32.91%) is better than 72.00% of its industry peers.
  • TR1's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 32.91%
PM (TTM) 28.18%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

  • TR1 has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TR1 has been reduced compared to 5 years ago.
  • TR1 has a better debt/assets ratio than last year.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • TR1 has an Altman-Z score of 5.89. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
  • TR1's Altman-Z score of 5.89 is amongst the best of the industry. TR1 outperforms 92.80% of its industry peers.
  • TR1 has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.03, TR1 belongs to the top of the industry, outperforming 98.40% of the companies in the same industry.
  • TR1 has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • TR1 has a better Debt to Equity ratio (0.00) than 89.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 5.89
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 2.76 indicates that TR1 has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.76, TR1 belongs to the top of the industry, outperforming 85.60% of the companies in the same industry.
  • TR1 has a Quick Ratio of 2.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.76, TR1 belongs to the top of the industry, outperforming 86.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.76
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

  • TR1 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.26%.
  • Measured over the past 5 years, TR1 shows a small growth in Earnings Per Share. The EPS has been growing by 2.42% on average per year.
  • The Revenue has been growing slightly by 4.26% in the past year.
  • The Revenue has been growing slightly by 4.78% on average over the past years.
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.87% on average over the next years.
  • TR1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.47% yearly.
EPS Next Y6.35%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
EPS Next 5Y4.87%
Revenue Next Year2.74%
Revenue Next 2Y4.16%
Revenue Next 3Y3.44%
Revenue Next 5Y1.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

  • TR1 is valuated reasonably with a Price/Earnings ratio of 11.47.
  • 84.00% of the companies in the same industry are more expensive than TR1, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, TR1 is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.32, the valuation of TR1 can be described as reasonable.
  • TR1's Price/Forward Earnings ratio is rather cheap when compared to the industry. TR1 is cheaper than 90.40% of the companies in the same industry.
  • TR1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.26.
Industry RankSector Rank
PE 11.47
Fwd PE 10.32
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TR1 is valued cheaper than 84.80% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TR1 indicates a somewhat cheap valuation: TR1 is cheaper than 73.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.12
EV/EBITDA 7.53
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • TR1 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.81
PEG (5Y)4.74
EPS Next 2Y5.83%
EPS Next 3Y3.92%

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.73%, TR1 is a good candidate for dividend investing.
  • TR1's Dividend Yield is a higher than the industry average which is at 3.01.
  • TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 4.73%

5.2 History

  • On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • 56.29% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
  • TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP56.29%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (1/15/2026, 7:00:00 PM)

92.76

+2.02 (+2.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-31
Earnings (Next)02-04
Inst Owners81.71%
Inst Owner ChangeN/A
Ins Owners1.69%
Ins Owner ChangeN/A
Market Cap20.24B
Revenue(TTM)7.21B
Net Income(TTM)2.03B
Analysts49.47
Price Target94 (1.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.73%
Yearly Dividend4.37
Dividend Growth(5Y)10.37%
DP56.29%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.28%
Min EPS beat(2)2.88%
Max EPS beat(2)9.67%
EPS beat(4)3
Avg EPS beat(4)2.48%
Min EPS beat(4)-5.31%
Max EPS beat(4)9.67%
EPS beat(8)6
Avg EPS beat(8)4.37%
EPS beat(12)10
Avg EPS beat(12)5.89%
EPS beat(16)11
Avg EPS beat(16)2.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.2%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-4.33%
Max Revenue beat(4)-1.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.88%
Revenue beat(12)2
Avg Revenue beat(12)-2.22%
Revenue beat(16)3
Avg Revenue beat(16)-2.74%
PT rev (1m)0%
PT rev (3m)5.24%
EPS NQ rev (1m)0.18%
EPS NQ rev (3m)6.81%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)5.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.99%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 11.47
Fwd PE 10.32
P/S 3.27
P/FCF 20.12
P/OCF 15.79
P/B 2.18
P/tB 2.99
EV/EBITDA 7.53
EPS(TTM)8.09
EY8.72%
EPS(NY)8.99
Fwd EY9.69%
FCF(TTM)4.61
FCFY4.97%
OCF(TTM)5.87
OCFY6.33%
SpS28.4
BVpS42.63
TBVpS31.05
PEG (NY)1.81
PEG (5Y)4.74
Graham Number88.09
Profitability
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROCE 18.12%
ROIC 13.51%
ROICexc 18.68%
ROICexgc 30.26%
OM 32.91%
PM (TTM) 28.18%
GM N/A
FCFM 16.23%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexgc growth 3Y-16.2%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.01
Cap/Depr 118.97%
Cap/Sales 4.45%
Interest Coverage 250
Cash Conversion 56.43%
Profit Quality 57.6%
Current Ratio 2.76
Quick Ratio 2.76
Altman-Z 5.89
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
EPS Next Y6.35%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
EPS Next 5Y4.87%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%
Revenue Next Year2.74%
Revenue Next 2Y4.16%
Revenue Next 3Y3.44%
Revenue Next 5Y1.47%
EBIT growth 1Y7.98%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year7.84%
EBIT Next 3Y6.45%
EBIT Next 5Y0.98%
FCF growth 1Y22.49%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y20.05%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%

T ROWE PRICE GROUP INC / TR1.DE FAQ

Can you provide the ChartMill fundamental rating for T ROWE PRICE GROUP INC?

ChartMill assigns a fundamental rating of 7 / 10 to TR1.DE.


What is the valuation status of T ROWE PRICE GROUP INC (TR1.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to T ROWE PRICE GROUP INC (TR1.DE). This can be considered as Undervalued.


Can you provide the profitability details for T ROWE PRICE GROUP INC?

T ROWE PRICE GROUP INC (TR1.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for TR1 stock?

The financial health rating of T ROWE PRICE GROUP INC (TR1.DE) is 9 / 10.


What is the expected EPS growth for T ROWE PRICE GROUP INC (TR1.DE) stock?

The Earnings per Share (EPS) of T ROWE PRICE GROUP INC (TR1.DE) is expected to grow by 6.35% in the next year.